Navigation Links
Low Acid Coffee Backed By Scientific Research
Date:3/27/2008

WOODLAND, Calif., March 27 /PRNewswire/ -- Puroast(R) Low Acid Coffee has conducted both chemistry and consumer research to confirm its claims that its great tasting, gourmet coffee provides symptom relief for those with stomach problems caused by their morning brew. Puroast(R) achieves this without extractions, substitutes or additives; it uses a natural process that helps ensure the full-bodied taste.

Prior chemistry research at University of California, Davis found Puroast(R) to have less than half the acid of all other commercial coffees. The company now announces first stage results of consumer research that shows nearly 90% of those tested experienced symptom relief when drinking Puroast(R) Low Acid Coffee.

"This is important research for both our company and the consumer," observed Kerry Sachs, co-founder of Puroast(R) Low-Acid Coffee. "When you combine these scientific studies with market data that indicates there are several million consumers who have stomach discomfort from coffee drinking, it's clear Puroast(R) has explosive market potential and delivers a strong consumer benefit."

Arthur R. Euler, MD, a gastroenterologist who directed Glaxo's Zantac(R) Clinical Development Unit, conducted a survey of 250 consumers who came to Puroast(R)'s website looking for a solution to their coffee-related gastrointestinal symptoms. Zantac(R) is a drug used to treat upper gastrointestinal symptoms and is often prescribed by primary care doctors. This research's objective was to evaluate Puroast(R) Low Acid Coffee's effect on these stomach symptoms.

"Our study asked consumers to brew and drink Puroast(R), then compare the symptoms that developed, if any, versus symptoms that developed when they drank other brands of coffee," states Dr. Euler. The survey also asked the participant to evaluate Puroast(R)'s taste. "88% of respondents stated Puroast(R) provided relief of their gut symptoms caused by coffee, and 95% said they would purchase the product again, taste being a key factor. These are extraordinarily high numbers for any product with its target consumer."

Puroast(R) and Dr. Euler are now expanding their study to include seeking input from those consumers who don't experience stomach problems from coffee. This is important for the company as it seeks to achieve "crossover" status - crossover products are those that satisfy both the consumer with the health issue and those only interested in taste. "These expanded studies will help us learn whether Puroast(R) can reach the same level of market penetration of other successful products such as diet sodas, light beer and low-fat yogurt".

Based in Woodland, Calif., Puroast(R) works with grocery retailers in educating the consumer about acid levels in coffee and the effect Puroast(R) Low Acid Coffee can have in reducing their coffee-related stomach discomfort. This effort has resulted in making Low Acid Coffee a new category in the US beverage marketplace.

Puroast(R) Low Acid Coffees can be found at leading grocery and specialty retailers nationwide including Ralph's, Bristol Farms, Albertson's, Publix, Hannaford, Giant Foods, Kroger, King Soopers, D'Agostino's, Sprouts, King Supermarkets, Frys, Mollie Stone's, Ray's, Andronicos, Save Mart and Costco Canada and Chicago.


'/>"/>
SOURCE Puroast
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
2. Industry Executives Finding Value in Shift of Scientific Publications
3. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
4. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
5. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
6. Second Thoughts about Fluoride, Reports Scientific American
7. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
8. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
9. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
10. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):